Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Sweden

 

Aleris buys Teres

Aleris, the Pan-Scandinavian hospital-to-elderly care group controlled by Investor has bought Teres, the pan-Scandinavian group which claims to be the largest elective surgery operator in the region. The move diversifies Aleris away from its dependence on Swedish public payors. We look at the deal in detail and talk to Teres CEO Ase Aulie Michelet.

Sweden’s dental market may consolidate despite pro-Praktikertjänst ruling

The Swedish Tax Authority (STA) has dropped its case against Sweden’s largest primary care and dentistry firm Praktikertjänst over under-priced shares. Sweden’s private sector is still held back by a law placing high taxes on dividends for companies with more than 20 shareholders. We talk to Praktikertjänst CEO, Johan Fredriksson and Per Rehnberg, CEO of dental organisation Colosseum Smile, about the impact of the law on Sweden’s dental market and Praktikertjänst’s future.

Laastari and Aleris to compete on telehealth?

Finnish outpatient provider, Laastari Lähiklinikka, and Swedish diversified healthcare service player, Aleris, are now both offering telehealth services in the Nordics. Both services claim to offer greater patient convenience in the outpatient primary care market. How do they differ and which model looks the most promising?

Global Health Partner reports strong growth in Nordics

Swedish-based Global Health Partner (GHP) has released its 2014 annual results, which show positive signs for future growth. GHP run a chain of ambulatory clinics offering the best breed of holistic treatment in the fields of orthopaedics, bariatric, arrhythmia, general surgery and dental care and have struggled for some time. But 2014 looks to be different; we talk to CEO Daniel Ohman about GHP’s best ever results.

Interview: Andreas Göthberg, CEO, Memira

Memira, the largest Scandinavian ophthalmology chain, backed by private equity house Investor Growth Capital, is now expanding operations into Finland. It had estimated 2014 sales of €60m. We talk to CEO Andreas Göthberg about growth trends, its business model, the importance of customer service and building a brand.

Sweden starts to unfreeze

The likelihood of a ban on for profits healthcare in Sweden is receding after the Social Democrats were forced before Christmas to turn to the right for support and as the far right Sweden Democrats have become more pragmatic. But the sector is not out of the woods yet.

Value-based reimbursement to hit Sweden

Value-based reimbursement (VBRs), a bundled payment system which replaces DRG, is set to be rolled out to breast cancer, diabetes, obstetrics, bariatric surgery, osteoporosis, hip and knee, spinal surgery and stroke patients in seven Swedish counties.

Interview: Bart Diels, Managing Partner, Head of Health & Care, Gimv

Listed investment company Gimv (Euronext: GIMB) is unusual in that it covers every aspect of health – biopharma, medtech and healthcare services – with a focus on mid-caps and a Pan-European approach. It is willing to invest as little as a few million euros up to € 50m and can hold a stake for up to 10-12 years. Active in biopharma since the early eighties, it has also made several investments in healthcare services and medical technologies. So how does Mr. Diels who has worked in VC and private equity for 20 years, view healthcare services as an investment perspective?

Find Us